Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States
Yizhen Lai, Arielle G. Bensimon, Emily Gao, Rituparna Bhattacharya, Ruifeng Xu, Jestinah Chevure, Kentaro Imai, Naomi B. Haas
Topics & Concepts
MedicinePembrolizumabRenal cell carcinomaNephrectomyAdjuvantOncologyInternal medicineKidney cancerCarcinomaUrologyImmunotherapyCancerKidneyRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis